Final height in children with medulloblastoma treated with growth hormone.

Author Department

Pediatrics

Document Type

Article, Peer-reviewed

Publication Date

2005

Abstract

BACKGROUND: Medulloblastoma is the most frequent primary solid central nervous system tumour in children. The 5-year survival rate is at present at about 60%. Height in general is severely compromised in survivors. The present study is an extension of the

Publication ISSN

0002-9378

Share

COinS